12:00 AM
Mar 23, 2009
 |  BC Week In Review  |  Company News  |  Deals

Biovitrum, Karolinska Development deal

Biovitrum and Karolinska formed an unnamed JV to develop and commercialize Biovitrum's low-molecular inhibitors of FMS-like tyrosine...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >